Xtx Topco LTD Sellas Life Sciences Group, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$0.84 - $1.35 $7,861 - $12,634	-9,359 Reduced 14.91%	53,426 $53,000
Q3 2024 Nov 14, 2024	BUY	$1.08 - $1.39 $67,807 - $87,271	62,785 New	62,785 $78,000
Q1 2024 May 13, 2024	SELL	$0.51 - $1.55 $12,841 - $39,027	-25,179 Reduced 59.15%	17,391 $17,000
Q4 2023 Feb 13, 2024	BUY	$0.88 - $1.57 $8,437 - $15,053	9,588 Added 29.07%	42,570 $45,000
Q3 2023 Nov 13, 2023	BUY	$1.42 - $1.83 $46,834 - $60,357	32,982 New	32,982 $54,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $5.41 $99,725 - $299,730	55,403 New	55,403 $130,000

14.5M

538K

26.3K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $39.9M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.